IDPH: Office of Disease Control

The purposes of the Illinois Department of Public Health Adult Vaccination Coverage Level Grant are to promote recommended immunizations for individuals, build partnerships with community-based organizations and health entities, provide education and resources to providers, and promote publicly funded vaccine programs, utilize media to increase immunization coverage levels, and address disparities in immunization access

Sections 317, 317(k)(2) of the Public Health Service Act (42 U.S.C. Sections 247b, 247b(k)(2) and 247c), as amended.

(20 ILCS 2310/2310-25)

N/A

1. At the discretion of the Department, identify at least four (4) communities or geographic clusters, in Illinois outside of Chicago, in which grant activities shall be focused. The communities or geographic areas shall be selected based on their lower vaccination rates, higher rates of school vaccine exemptions, and/or higher incidence of vaccine preventable diseases. Grantee activities shall address all routinely recommended vaccines, including season flu vaccine and/or on the Recommended Adult Immunization Schedule for Ages 19 Years or Older, depending on the age group(s) selected by the grantee. At IDPH's discretion, applicants may be awarded a grant to address needs around a specific vaccine or a recommendation limited to a specific age group. 2. Consider choosing new communities or geographic clusters to focus your scope of work for year two (2). If previously selected communities or geographic clusters from year one are going to be the same for year two due to an outstanding circumstance or heavy need of coverage focus, justification will need to be provided. 3. Promote provider enrollment in the Immunization Information System (IIS) regardless of the provider’s enrollment in a publicly funded vaccine program. Provide education and resources to health care providers to support timely immunizations. Promote provider enrollment in publicly funded vaccine programs including 317 and, if the provider is a target provider type, the COVID-19 Bridge Access Program. 4. Build partnerships with community partners, health entities, and other stakeholders to conduct evidence-based activities that reduce exclusion rates of students, increase public awareness of the safety of vaccinations and their effectiveness in preventing disease, promote vaccine confidence, reduce barriers to vaccination, and increase the vaccination coverage levels among the selected population for all recommended adult vaccinations. 5. Implement a public immunization campaign through a variety of media sources, including print, radio, tv, and targeted social media marketing, to educate, empower, and mobilize targeted communities and support the objectives of increase vaccine uptake. 6. Acquire Department approval on all materials produced with grant funds prior to printing, broadcast, or publication. Upon approval by the Department, all brochures, booklets, flyers, journal articles, programs, advertisements (including print and out-of-home). Multimedia presentations, videos, and other printed or electronic materials (including but not limited to Web Sites) prepared with funds from this grant shall include the following statement: Funding for this (event, publication, etc.) was made possible by funds received from the Office of Health Protection, through the Illinois Department of Public Health. 7. Participate in quarterly conference calls with appropriate Department immunization staff to discuss progress with initiatives, provide updates and feedback on activities, and utilize IDPH staff to review proposed documents, as requested by the Department. 8. Submit a Monthly Activity Summary Report and Reimbursement Request by the 30th of each month following the end of the month to include a status update on each scope of service, challenges, and significant successes.

Yes

01/01/2024 - 12/31/2024

Government Organizations; Nonprofit Organizations;

EverThrive Illinois, Illinois Academy of Family Physicians, and Illinois Public Health Association

N/A

Direct Payments for Specific Use

Healthcare

N/A

Regardless of the source of funding (federal pass-through or State), all grantees are required to register with the State of Illinois through the Grant Accountability and Transparency Act (GATA) website, www.grants.illinois.gov, complete a prequalification process, and be determined "qualified" as described in Section 7000.70. Registration and prequalification is required before an organization can apply for an award. The entity is "qualified" to be an awardee if it: 1) has an active DUNS number; 2) has an active SAM.gov account; 3) has an acceptable fiscal condition; 4) is in good standing with the Illinois Secretary of State, if the Illinois Secretary of State requires the entity's organization type to be registered. Governmental entities, school districts and select religious organizations are not required to be registered with the Illinois Secretary of State. Refer to the Illinois Secretary of State Business Services website: http://www. cyberdriveillinois.com/departments/business_services/home.html; 5) is not on the Illinois Stop Payment List; 6) is not on the SAM.gov Exclusion List; 7) is not on the Sanctioned Party List maintained by HFS.

Applicants will utilize the IDPH EGRAMS database to submit their grant application. https://idphgrants.com/ Please utilize the instructional guide. https://idphgrants.com/admin/ViewAppDocs.aspx?fnam=EGrAMS%20Instructional%20Guide%20-%20Initiate%20Grant%20App%20YBD.pdf

The Adult Vaccination Coverage Level -2024 is a non-competitive renewal of the Adult Vaccination Coverage Level -2023 competitive grant. All eligible applicants will receive a grant award. There are no merit-based review criteria for evaluation of the applications, and all applications will be reviewed for completeness and accuracy. Applications with insufficient information required will be returned to the applicant for corrections and re-submission.

Adult Vaccination Coverage Level are non-competitive and not formula based. All applicants that submit completed applications by the deadline will receive a grant award. Applications will be reviewed by the Office of Disease Control – Immunization Section. If criteria are met, the application will be considered successful. Grant will be awarded upon acceptance of the Notice of State award by signing the Uniform Grant Agreement by the grantee and the Director of the Illinois Department of Public Health

Grant application must be submitted through EGrAMS by 4:59 pm, December 30th, 2023. A grant application must first be validated to ensure it is free of errors. The applicant must then promote the application to the Authorized Official Certification stage. The applicant must then complete all fields in the Certification section, save the application, and submit it to IDPH for review. The applicant shall receive an e-mail generated by EGrAMS to indicate the application has been submitted and received.

IDPH expects to complete initial review of each Adult Vaccination Coverage Level Grant application as soon as possible after receipt but no later than 4 weeks after receipt of application. Final approval of the grant applications in EGrAMS cannot be completed until all internal IDPH approvals have been obtained. Grant agreements under the Adult Vaccination Coverage Level Grant Program will be effective January 1, 2023, regardless of the timing of the final EGrAMS approval

N/A

N/A

N/A

Use of Funds. All grant funds must be used for the sole purposes set forth in the grant proposal and application and must be used in compliance with all applicable laws. Grant funds may not be used as matching funds for any other grant program. Use of grant funds for prohibited purposes may result in loss of grant award and/or place the grantee at risk for recouping of those funds used for the prohibited purpose. Expenditure reports must be submitted quarterly. Funds are to be restricted to the approved budget in the grant application. Changes and amendments to the use of funds must be approved through a written communication from IDPH. Unallowable or prohibited use of grant funds include, but are not limited to the following: -Recipients may not use funds for research -Recipients may not use funds for clinical care except as allowed by law. This restriction does not prohibit the use of IP19-1901 funding for vaccination activities, including the direct administration of vaccines. -Fundraising or legislative lobbying expenses -Recipients may use funds only for reasonable program purposes, including personnel, travel, supplies, and services. -Generally, recipients may not use funds to purchase furniture or equipment. Any such proposed spending must be clearly identified in the budget. -Reimbursement of pre-award costs generally is not allowed, unless the CDC provides written approval to the recipient. -Other than for normal and recognized executive-legislative relationships, no funds may be used for: - publicity or propaganda purposes, for the preparation, distribution, or use of any material designed to support or defeat the enactment of legislation before any legislative body -the salary or expenses of any grant or contract recipient, or agent acting for such recipient, related to any activity designed to influence the enactment of legislation, appropriations, regulation, administrative action, or Executive order proposed or pending before any legislative body -See Additional Requirement (AR) 12 for detailed guidance on this prohibition and additional guidance on lobbying for CDC recipients. -The direct and primary recipient in a cooperative agreement program must perform a substantial role in carrying out project outcomes and not merely serve as a conduit for an award to another party or provider who is ineligible. -In accordance with the United States Protecting Life in Global Health Assistance policy, all non-governmental organization (NGO) applicants acknowledge that foreign NGOs that receive funds provided through this award, either as a prime recipient or subrecipient, are strictly prohibited, regardless of the source of funds, from performing abortions as a method of family planning or engaging in any activity that promotes abortion as a method of family planning, or to provide financial support to any other foreign non-governmental organization that conducts such activities. See Additional Requirement (AR) 35 for applicability https://www.cdc.gov/grants/additionalrequirements/ar-35.htm

The grantee is required to submit monthly progress reports on their work plan objectives. Failure to submit required reports in a timely manner will result in delays with approval of reimbursements. The grantee will ensure monthly reports are submitted in the provided format as follows: EGrAMS templates.

Article XV Audit Requirements: Audits Grantee shall be subject to the audit requirements contained in the Single Audit Act Amendments of 1996 (31 USC 7501-7507) and Subpart F of 2 CFR Part 200, and the audit rules and policies set forth by the Governor’s Office of Management and Budget. See 30 ILCS 708/65(c); 44 Ill. Admin. Code 7000.90.

Grantee shall maintain for three (3) years from the date of submission of the final expenditure report, adequate books, all financial records and, supporting documents, statistical records, and all other records pertinent to this Award, adequate to comply with 2 CFR 200.333, unless a different retention period is specified in 2 CFR 200.333 or 44 Ill. Admin. Code §§ 7000.430(a) and (b).

063-48250-1900-0099

N/A

$125,000-$150,000

Increase vaccination acceptance and coverage levels amongst in the identified communities. •Address the specific needs of the identified populations through various media avenues. •Ensure equitable investments in the identified geographic clusters. •Promote ACIP and CDC vaccine recommendations to the targeted populations. •Promote RSV Vaccine amongst high-risk adult population. •Identify communities with immunization coverage level gaps. •Develop an assessment tool to identify factors that contribute to gaps in immunization rates in identified communities.

N/A

N/A

Springfield, IL

N/A

Pediatric Vaccination Coverage Level

N/A

11/7/2022

FY 2023 : $225,000
FY 2024 : $225,000
FY 2025 : $225,000